SuperworthMovado profit margin MOV
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- 6.0%
- Operating margin, 12 months
- 6.9%
- Net margin on a year earlier
- +3.4 pts
- Peer median
- 6.5%
Over the twelve months to Jul 31, 2026, Movado kept 6.0% of its revenue as net profit, with an operating margin of 6.9% and a gross margin of 56.1%.
Five years earlier its net margin was 11.3%.
The median for 10 medical instruments and supplies stocks of a similar size is 6.5%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2026 | 4.0% | 4.4% | 54.2% |
| FY2025 | 2.8% | 3.1% | 54.0% |
| FY2024 | 6.2% | 7.3% | 54.8% |
| FY2023 | 12.6% | 16.0% | 57.7% |
| FY2022 | 12.5% | 16.0% | 57.2% |
| FY2021 | −22.0% | −28.1% | 53.4% |
| FY2020 | 6.1% | 6.1% | 53.5% |
| FY2019 | 9.1% | 9.2% | 54.4% |
| FY2018 | −2.7% | 7.6% | 52.5% |
| FY2017 | 6.3% | 9.8% | 53.3% |
| FY2016 | 7.6% | 11.8% | 53.3% |
| FY2015 | 8.8% | 12.2% | 52.8% |
| FY2014 | 8.9% | 11.9% | 53.5% |
| FY2013 | 11.3% | 9.8% | 55.0% |
| FY2012 | 6.8% | 7.2% | 54.8% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY27 | 6.0% | +3.4 pts | 6.9% | |
| Q1 FY27 | 4.7% | +2.0 pts | 5.4% | |
| Q4 FY26 | 4.0% | +1.1 pts | 4.4% | |
| Q3 FY26 | 3.3% | +0.2 pts | 3.8% | |
| Q2 FY26 | 2.6% | −2.1 pts | 3.0% | |
| Q1 FY26 | 2.7% | −2.4 pts | 2.8% | |
| Q4 FY25 | 2.8% | −3.4 pts | 3.1% | |
| Q3 FY25 | 3.1% | −4.8 pts | 3.3% | |
| Q2 FY25 | 4.7% | −4.9 pts | 5.2% | |
| Q1 FY25 | 5.2% | −6.5 pts | 6.0% | |
| Q4 FY24 | 6.2% | −6.3 pts | 7.3% | |
| Q3 FY24 | 7.9% | −5.6 pts | 9.3% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Movado's size, closest first, today.
| Company | Profit margin |
|---|---|
| MOVMovado | 6.0% |
| MDXGMimedx | 1.8% |
| TCMDTactile Systems Technology | 7.1% |
| IRMDIradimed | 26.7% |
| STAAStaar Surgical | 1.1% |
| BVSBioventus | 9.4% |
| CDRECadre | 5.3% |
| EMBCEmbecta | 8.6% |
| EYENational Vision | 2.5% |
| INFUInfuSystem | 6.0% |
| LMATLemaitre Vascular | 25.0% |
| Peer median | 6.5% |
Where Movado ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Movado
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.